The anti-translocation and anti-inflammatory effect of cinnamon oil in mice with TNBS induced colitis

Dobroslava Bujňáková 1 , Štefan Juhás 2 , and Štefan Faix 1
  • 1 Institute of Animal Physiology, Slovak Academy of Sciences, Soltesovej 4/6, SK-04001, Kosice, Slovakia
  • 2 Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov, Czech Republic


The bacterial translocation induced by colitis may cause the organ failure and sepsis. Therefore, it is necessary to find new possibilities for prevention and therapy of this problem. The purpose of this study was to examine Escherichia coli anti-translocation activity of cinnamon oil and its ability to reduce colonic damage in mice with TNBS (2,4,6-trinitrobenzenesulfonic acid) induced colitis. Mice received cinnamon essential oil in four various concentrations (0.5%, 0.25%, 0.125% and 0.063%) in the powdery commercial rodent diet, starting 21 days before induction of TNBS colitis. The colonic damage was assessed using the colon macroscopic scoring system (Wallace score). E. coli translocation to the mesenteric lymphatic nodules was evaluated by serial dilutions method for counting bacteria. Bacterial translocation was significantly reduced in first and third group (15.2% or 42.8% in cinnamon oil groups versus 100% in TNBS group). Cinnamon oil was effective also against the colonic damage in all cinnamon oil groups (macroscopically scores of grade 9 in TNBS group versus 5.25, 5.63, 5.13 and 3.25 in cinnamon oil groups). Our results confirmed that dietary administration of cinnamon oil could possess potential therapeutic effects on bacterial translocation and intestinal wall injury in colitis.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Akcan A., Kucuk C., Sozuer E., Esel D., Akyildiz H., Akgun H., Muhtaroglu S. & Aritas Y. 2008. Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acidinduced colitis of rats. World J. Gastroenterol. 14(6): 918–924. PMID: 18240350

  • [2] Baser K.H.C. & Buchbauer G. 2010. Handbook of Essential Oils: Science, Technology and Applications. CRC Press, Boca Raton, London, New York, 994 pp. ISBN: 978-1-4200-6315-8.

  • [3] Capasso R., Pinto L., Vuotto M.L. & Di Carlo G. 2000. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. Fitoterapia 71(1): 131–137. DOI: 10.1016/S0367-326X(00)00188-X

  • [4] Clayburgh D.R., Shen L. & Turner J.R. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282–291. PMID: 14767487

  • [5] Fabián D., Sabol M., Domaracká K. & Bujňáková D. 2006. Essential oils-their antimicrobial activity against Escherichia coli and effect on intestinal cell viability. Toxicology in Vitro 20(8): 1435–1445. DOI: 10.1016/j.tiv.2006.06.012

  • [6] Horosová K., Bujňáková D. & Kmeť V. 2004. Antimikrobiálne účinky rastlinných silíc na E. coli z poodstavovej hnačky [Antimicrobial effects of essential oils on E. coli from postweaning diarrhoea]. Slov. Vet. Čas. 29(5): 30–31.

  • [7] Huang K.F., Chung D.H. & Herndon D.N. 1993. Insulin-like growth factor 1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn 2 injury. Arch. Surg. 128: 47–54. DOI: 10.1001/archsurg.1993.01420130051009

  • [8] Chao L.K., Hua K., Hsu H., Cheng S., Liu J. & Chang S. 2005. Study on the Antiinflammatory activity of essential oil from leaves of Cinnamomum osmophloeum. J. Agric. Food Chem. 53: 7274–7278. DOI: 10.1021/jf051151u

  • [9] Lichtenstein G.R., Abreu M.T., Cohen R. & Tremaine W. 2006. American Gastroenterological Association. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infl iximab in inflammatory bowel disease. Gastroenterology 130: 940–987. PMID: 16530532

  • [10] Lopez P., Sanchez C., Batlle R. & Nerin C. 2005. Solid and vapor-phase antimicrobial activities of six essential oils: susceptibility of selected foodborne bacterial and fungal strains. J. Agric. Food Chem. 53(17): 6939–6946. DOI: 10.1021/jf050709v

  • [11] Mau J.L., Chen C.P. & Hsieh P.C. 2001. Antimicrobial effect of extracts from Chinese Chive, Cinnamon, and Corni Fructus J. Agric. Food Chem. 49(1): 183–188. DOI: 10.1021/jf000263c

  • [12] Neurath M.E., Fuss I., Kelsall B.L., Stüber E. & Strober W. 1995. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281–1290. DOI: 10.1084/jem.182.5.1281

  • [13] Schelz Z., Joseph M. & Judit. H. 2006. Antimicrobial and antiplasmid activities of essential oils. Fitoterapia 77(4): 279–285. DOI: 10.1016/j.fitote.2006.03.013

  • [14] Srinivasan K. 2005. Role of spices beyond food flavoring: Nutraceuticals with multiple health effects. Food Rev. Int.21: 167–188. DOI: 10.1081/FRI-200051872

  • [15] Stein J., Ries J. & Barrett K.E. 1998. Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am. J. Physiol. 274(Pt. 1): G203–G209.

  • [16] Wallace J.L., MacNaughton W.K., Morris G.P. & Beck P.L. 1989. Inhibition of leukotriene synthesis markedly enhances healing in an animal model of inflammatory bowel disease. Gastroenterology 96: 29–36.

  • [17] Weber C.R. & Turner J.R. 2007. Inflammatory bowel disease: is it really just another break in the wall? Gut 56: 6–8. PMID: 17172583


Journal + Issues